Literature DB >> 30992813

Hepatitis B virus treatment: Which patients can have treatment deferred?

George V Papatheodoridis1.   

Abstract

Entities:  

Year:  2013        PMID： 30992813      PMCID： PMC6448612          DOI： 10.1002/cld.160

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  2 in total

1.  Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.

Authors:  Ana Isabel Gil-García; Antonio Madejón; Irene Francisco-Recuero; Ana López-López; Emiliana Villafranca; Miriam Romero; Araceli García; Antonio Olveira; Rocío Mena; Juan Ramón Larrubia; Javier García-Samaniego
Journal:  World J Gastroenterol       Date:  2019-10-14       Impact factor: 5.742

2.  Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients.

Authors:  Maria Francesca Cortese; Carolina González; Josep Gregori; Rosario Casillas; Luca Carioti; Mercedes Guerrero-Murillo; Mar Riveiro-Barciela; Cristina Godoy; Sara Sopena; Marçal Yll; Josep Quer; Ariadna Rando; Rosa Lopez-Martinez; Beatriz Pacín Ruiz; Selene García-García; Rafael Esteban-Mur; David Tabernero; Maria Buti; Francisco Rodríguez-Frías
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.